Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CDMO Avid Bioservices, Inc.

盘前交易 12-23 04:18:11 EST

12.30

-0.03

-0.24%

最高12.34	最低12.29	成交量106.05万
今开12.31	昨收12.33	日振幅0.41%
总市值7.87亿	流通市值6.22亿	总股本6,396万
成交额1,305万	换手率2.10%	流通股本5,061万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":12.3,"timestamp":1734728400000,"preClose":12.33,"halted":0,"volume":1060535,"delay":0,"floatShares":50608564,"shares":63963302,"eps":-2.394638,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.03,"latestTime":"12-23 04:18:11 EST","open":12.31,"high":12.34,"low":12.29,"amount":13053528.233795,"amplitude":0.004055,"askPrice":12.39,"askSize":342,"bidPrice":12.11,"bidSize":342,"shortable":3,"etf":0,"ttmEps":-2.394638,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"adjPreClose":12.3,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":12.27,"preClose":12.3,"latestTime":"18:27 EST","volume":78532,"amount":965861.0305,"timestamp":1734737276599},"volumeRatio":1.0264367705937825,"impliedVol":0.8913,"impliedVolPercentile":0.58},"requestUrl":"/m/hq/s/CDMO/tweets","defaultTab":"tweets","newsList":[{"id":"2493772932","title":"台州博士造药狂飙，剑指200个亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2493772932","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493772932?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:40","pubTimestamp":1734918047,"startTime":"0","endTime":"0","summary":"记者丨韩璐浙商俞德超控制的信达生物，狂飙突进。12月20日，他签发公告宣布，达伯乐?（己二酸他雷替尼胶囊）新药上市申请获批，成为信达第13款商业化产品，将惠及ROS1突变的肺癌患者。“2027年完成20款产品上市。”董事长、CEO俞德超正火力全开，旗下组合格外丰富，从三期临床到上市获批的各类新药，超过30款。1-9月，信达产品收入已超60亿元，增长超5成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412233275582845.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412233275582845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2493428432","title":"Scorpius Holdings, Inc.盘中异动 快速下跌12.89%报0.333美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493428432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493428432?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:32","pubTimestamp":1734705125,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时32分，Scorpius Holdings, Inc.股票出现异动，股价急速跳水12.89%。Scorpius Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 、Aptose Biosciences, Inc.涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1729.33%、78.24%、54.77%，振幅较大的相关个股有Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 、Psyence Biomedical Ltd.，振幅分别为22.54%、16.80%、16.26%。Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223205ab8764c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223205ab8764c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","SCPX","BK4139"],"gpt_icon":0},{"id":"2492159465","title":"Lifecore Biomedical, Inc.盘中异动 临近收盘快速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492159465?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:38","pubTimestamp":1734554293,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时38分，Lifecore Biomedical, Inc.股票出现波动，股价大幅下挫5.15%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为1.41%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043813ab829f9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043813ab829f9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LFCR","BK4121","BK4212","CDMO"],"gpt_icon":0},{"id":"2492181511","title":"Scorpius Holdings, Inc.盘中异动 大幅上涨9.04%报0.324美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492181511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492181511?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:34","pubTimestamp":1734532479,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时34分，Scorpius Holdings, Inc.股票出现异动，股价急速上涨9.04%。Scorpius Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Cognition Therapeutics, Inc.、Tc Biopharm  Plc、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Cognition Therapeutics, Inc.、Tc Biopharm  Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为311.53%、245.15%、91.85%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Tc Biopharm  Plc，振幅分别为66.83%、48.36%、30.15%。Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223442ab82078c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223442ab82078c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4007","BK4139","SCPX","CGTX"],"gpt_icon":0},{"id":"2492393559","title":"乐普生物与乐普医疗CDMO服务关联交易预计2025年上限为3600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492393559","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492393559?lang=zh_cn&edition=full","pubTime":"2024-12-17 17:14","pubTimestamp":1734426850,"startTime":"0","endTime":"0","summary":"财中社12月17日电乐普生物-B（02157）发布公告，提及与乐普医疗签订的CDMO服务框架协议，该协议于2024年11月26日达成，内容包括为乐普医疗及其附属公司提供药物开发相关的CDMO服务及设备。协议的有效期为2025年1月1日至2025年12月31日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412173270896942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK4139","02157","CDMO"],"gpt_icon":0},{"id":"2491037957","title":"Lifecore Biomedical, Inc.盘中异动 早盘快速下挫5.14%报7.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491037957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491037957?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:01","pubTimestamp":1734102111,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时01分，Lifecore Biomedical, Inc.股票出现波动，股价大幅下跌5.14%。截至发稿，该股报7.19美元/股，成交量6043股，换手率0.02%，振幅3.83%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.03%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213230151ab759b7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213230151ab759b7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LFCR","BK4183","CDMO","FLGC","BK4121","BK4212","BK4539"],"gpt_icon":1},{"id":"2491433755","title":"Scorpius Holdings, Inc.盘中异动 股价大跌7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491433755","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491433755?lang=zh_cn&edition=full","pubTime":"2024-12-13 01:42","pubTimestamp":1734025341,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日01时42分，Scorpius Holdings, Inc.股票出现异动，股价大幅下跌7.57%。Scorpius Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213014221984b9dc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213014221984b9dc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","SCPX","BK4139"],"gpt_icon":0},{"id":"2490338766","title":"Lifecore Biomedical, Inc.盘中异动 大幅下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490338766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490338766?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:43","pubTimestamp":1734018237,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时43分，Lifecore Biomedical, Inc.股票出现异动，股价急速下挫5.15%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.29%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121223435795e939c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121223435795e939c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO","LFCR","BK4212","BK4121"],"gpt_icon":0},{"id":"2490800988","title":"更新 4-龙沙退出保健品和配料业务，专注于合同开发，寻求交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2490800988","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490800988?lang=zh_cn&edition=full","pubTime":"2024-12-12 20:47","pubTimestamp":1734007675,"startTime":"0","endTime":"0","summary":"分析师说，计划中的 CHI 退出应能消除龙沙增长的阻力，并加强其资产负债表，尽管这将导致非现金减记。该公司告诉投资者，它将在2025年确定与CHI有关的下一步措施，因为它将专注于为制药公司生产药品的合同开发和制造组织 业务。龙沙财务总监迪克告诉记者，龙沙还将更加注重并购，寻找 \"技术或能力方面的绝佳机会\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","LU2237443549.SGD","LU0238689110.USD","LU1093756325.SGD","LLY","LU1057294990.SGD","LU2491049909.HKD","LU0289739699.SGD","IE0004445239.USD","LU1868837300.USD","IE0009355771.USD","LU1917777945.USD","LU1868836757.USD","LU0354030511.USD","LU0256863811.USD","LU0096364046.USD","LU1267930730.SGD","LU2468319806.SGD","SG9999015952.SGD","LU0820561818.USD","LU2265009873.SGD","BK4599","LU0466842654.USD","SGXZ31699556.SGD","CHI","IE00BJT1NW94.SGD","LU0471298694.HKD","SGXZ81514606.USD","LU0061475181.USD","SG9999018857.SGD","LU2237438978.USD","LU1623119135.USD","LU1868836591.USD","LU2237443622.USD","LU1988902786.USD","LU1291159041.SGD","BK4581","LU2237443978.SGD","BK4585","LU2361045086.USD","LU2361044949.HKD","BK4534","LU1093756168.USD","IE00B1BXHZ80.USD","LU1804176565.USD","LU1551013425.SGD","LU2237443382.USD","LU0006306889.USD","LU1064131342.USD","LU0882574055.USD"],"gpt_icon":1},{"id":"2490896470","title":"Lifecore Biomedical, Inc.盘中异动 下午盘大幅上涨5.01%报7.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490896470","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490896470?lang=zh_cn&edition=full","pubTime":"2024-12-12 02:07","pubTimestamp":1733940434,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日02时07分，Lifecore Biomedical, Inc.股票出现波动，股价急速上涨5.01%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.47%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121202071495e900a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121202071495e900a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4212","CDMO","LFCR","BK4139"],"gpt_icon":0},{"id":"2490886818","title":"Scorpius Holdings, Inc.股价飙升10.37% 市值涨17.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490886818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490886818?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:30","pubTimestamp":1733927405,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时30分，Scorpius Holdings, Inc.股票出现波动，股价大幅上涨10.37%。Scorpius Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Scorpius Holdings, Inc.、Calidi Biotherapeutics, Inc.、珐博进涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为363.25%、97.87%、96.99%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223005ab6fc8cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223005ab6fc8cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SCPX","CDMO"],"gpt_icon":0},{"id":"2490022496","title":"Avid Bioservices Inc 报告截至 10 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2490022496","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490022496?lang=zh_cn&edition=full","pubTime":"2024-12-11 06:14","pubTimestamp":1733868895,"startTime":"0","endTime":"0","summary":"Avid Bioservices Inc 报告截至 10 月 31 日的季度业绩 - 收益摘要Avid Bioservices Inc CDMO.OQ报告，截至10月31日的季度调整后每股亏损27美分，低于去年同期的每股收益-15美分。五位分析师对该季度的平均预期是每股亏损 12 美分。Avid Bioservices Inc公布的本季度每股收益为亏损27美分。该公司的季度亏损额为 1740 万美元。Avid Bioservices Inc的股价本季度上涨了7.8%，今年迄今为止上涨了88.8%。华尔街对 Avid Bioservices 公司 12 个月目标价的中位数为 12.50 美元。本摘要由 LSEG 12 月 10 日 10:14 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nL4S3NB1TK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"1185343713","title":"Avid Bioservices第二季度每股亏损0.27美元， 错失预期的0.12美元，销售额3350万美元，错失预期的3380万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185343713","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185343713?lang=zh_cn&edition=full","pubTime":"2024-12-11 05:24","pubTimestamp":1733865892,"startTime":"0","endTime":"0","summary":"Avid Bioservices 报告其季度每股亏损为0.27美元，较分析师普遍预期的0.12美元低了125%。与去年同期每股亏损0.15美元相比，减少了80%。以上内容来自Benzinga Earnings专栏，原文如下：Avid Bioservices  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 125 percent. This is a 80 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $33.50 million which missed the analyst consensus estimate of $33.80 million by 0.89 percent.  This is a 31.89 percent increase over s","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMOP","CDMO"],"gpt_icon":0},{"id":"2490401775","title":"Scorpius Holdings, Inc.盘中异动 早盘大幅下跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490401775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490401775?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:49","pubTimestamp":1733845792,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时49分，Scorpius Holdings, Inc.股票出现异动，股价急速下挫5.38%。Scorpius Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1933.24%、448.16%、138.34%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Uniqure N.V.，振幅分别为154.91%、131.78%、44.00%。Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210234952984b1009&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210234952984b1009&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO","SCPX"],"gpt_icon":0},{"id":"2490775554","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490775554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490775554?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:49","pubTimestamp":1733755751,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时49分，Lifecore Biomedical, Inc.股票出现异动，股价快速上涨5.18%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.65%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224911ab6a1392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224911ab6a1392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4212","CDMO","LFCR","BK4139"],"gpt_icon":0},{"id":"2489023285","title":"Scorpius Holdings, Inc.盘中异动 早盘急速下挫6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489023285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489023285?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:25","pubTimestamp":1733498726,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时25分，Scorpius Holdings, Inc.股票出现波动，股价大幅下挫6.29%。Scorpius Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Adc Therapeutics Sa、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Telomir Pharmaceuticals, Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为52.68%、40.22%、27.75%，振幅较大的相关个股有Adc Therapeutics Sa、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为33.33%、27.68%、26.58%。Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232526a1d98c1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232526a1d98c1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SCPX","CDMO"],"gpt_icon":0},{"id":"2489905584","title":"Lifecore Biomedical, Inc.盘中异动 下午盘股价大跌5.12%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489905584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489905584?lang=zh_cn&edition=full","pubTime":"2024-12-06 04:27","pubTimestamp":1733430422,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日04时27分，Lifecore Biomedical, Inc.股票出现异动，股价急速下挫5.12%。截至发稿，该股报7.22美元/股，成交量8.0148万股，换手率0.22%，振幅5.65%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.61%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206042702a1d73a59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206042702a1d73a59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BFRI","CDMO","LFCR","BK4212","BK4121","BK4139"],"gpt_icon":0},{"id":"2489672294","title":"Scorpius Holdings, Inc.盘中异动 股价大跌5.24%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489672294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489672294?lang=zh_cn&edition=full","pubTime":"2024-12-06 01:06","pubTimestamp":1733418401,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日01时06分，Scorpius Holdings, Inc.股票出现异动，股价大幅下挫5.24%。截至发稿，该股报0.470美元/股，成交量3.5997万股，换手率0.83%，振幅8.41%。Scorpius Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206010641971be80b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206010641971be80b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCPX","BK4139","CDMO"],"gpt_icon":0},{"id":"2489483099","title":"美国研究综述-Autozone, Costco Wholesale, Salesforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2489483099","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489483099?lang=zh_cn&edition=full","pubTime":"2024-12-05 15:19","pubTimestamp":1733383180,"startTime":"0","endTime":"0","summary":"    路透社12月5日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Autozone、好市多批发公司和 Salesforce。要闻  * Autozone Inc   ：摩根大通将目标价从3275美元上调至3400美元 * 好市多批发公司  ：摩根大通将目标价从945美元上调至1090美元 * Salesforce Inc   ：汇丰银行将目标价从326美元上调至413美元 以下是路透社周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMX","CPB","NCNO","CDMO","COST","CHPT","DLTR","AZO","CCRN","ASB","PRO","CHWY","RLMD","CRM","EW","FL","CXM","GXO"],"gpt_icon":1},{"id":"2488197576","title":"Scorpius Holdings, Inc.盘中异动 大幅上涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488197576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488197576?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:37","pubTimestamp":1733323037,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时37分，Scorpius Holdings, Inc.股票出现波动，股价大幅上涨6.16%。Scorpius Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为1351.76%、198.64%、114.79%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Eterna Therapeutics Inc.、Heron Therapeutics, Inc.，振幅分别为53.42%、35.78%、31.36%。Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223718abf5cba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223718abf5cba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4139","SCPX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avidbio.com","stockEarnings":[{"period":"1week","weight":-0.0032},{"period":"1month","weight":0.0065},{"period":"3month","weight":0.0603},{"period":"6month","weight":0.6313},{"period":"1year","weight":0.9189},{"period":"ytd","weight":0.8923}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avid Bioservices, Inc.最初于1981年6月在美国加州注册成立，并于1996年9月25日在美国特拉华州重新合并。该公司是一家专门的合同开发和制造组织（“CDMO”），提供从工艺开发到当前良好制造实践的全方位服务（“CGMP”）临床和商业制造，专注于从哺乳动物细胞培养中提取生物制药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.633333,"avgChangeRate":0.252871},{"month":2,"riseRate":0.566667,"avgChangeRate":0.058259},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.035156},{"month":4,"riseRate":0.4,"avgChangeRate":-0.032334},{"month":5,"riseRate":0.516129,"avgChangeRate":0.109027},{"month":6,"riseRate":0.419355,"avgChangeRate":0.007765},{"month":7,"riseRate":0.322581,"avgChangeRate":0.039463},{"month":8,"riseRate":0.354839,"avgChangeRate":0.002481},{"month":9,"riseRate":0.387097,"avgChangeRate":-0.046446},{"month":10,"riseRate":0.354839,"avgChangeRate":-0.040707},{"month":11,"riseRate":0.548387,"avgChangeRate":0.073378},{"month":12,"riseRate":0.419355,"avgChangeRate":0.023687}],"exchange":"NASDAQ","name":"Avid Bioservices, Inc.","nameEN":"Avid Bioservices, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Avid Bioservices, Inc.(CDMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Avid Bioservices, Inc.,CDMO,Avid Bioservices, Inc.股票,Avid Bioservices, Inc.股票老虎,Avid Bioservices, Inc.股票老虎国际,Avid Bioservices, Inc.行情,Avid Bioservices, Inc.股票行情,Avid Bioservices, Inc.股价,Avid Bioservices, Inc.股市,Avid Bioservices, Inc.股票价格,Avid Bioservices, Inc.股票交易,Avid Bioservices, Inc.股票购买,Avid Bioservices, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Avid Bioservices, Inc.(CDMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}